Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
07 February 2018 Photo Facebook
Louzanne and Marné included in national student cross country teams
Athlete Louzanne Coetzee, and her guide, Xavier Adams

Two Kovsie athletes, including the blind athlete and world record holder, Louzanne Coetzee, have been included in the national student cross country team.

Coetzee and Marné Mentz will compete at the World Student Cross Country championship on 7 April in St Gallen in Switzerland.

They qualified for the team after good performances at the Athletics South Africa’s cross country trials held at the University of the Free State (UFS) on 20 January. The distance was over 10km.

What makes Coetzee’s inclusion even more remarkable is the fact that she will be competing against able-bodied runners. The world record holder in the 5 000m in her disability category (T-11) and her new guide, Xavier Adams, finished first among the female students in a time of 39:32, which is her personal best. Mentz ended in second place for students in 39:44. They will make up two of the six spots in the women’s team in Switzerland.

First for Coetzee

It is the first time that Coetzee was chosen for an able-bodied national team. She is doing a master’s degree in Reconciliation and Social Cohesion this year and Mentz is in her final year of a BEd Intermediate Phase.

Tshepang Sello, another Kovsie and an Olympic athlete from Lesotho, took first position for students in 38:04 but did not qualify for the South African team because of her Lesotho citizenship.

Kesa Molotsane (35:29) was the overall winner. Although Molotsane is still doing her honours this year, she ran in the open division as she no longer qualifies as a student because she is over the age of 25, according to University Sport South Africa regulations.

Molotsane ,26, is the national cross country champion of 2016 and obtained second spot last year.

News Archive

DNA sequencer launched at the UFS
2013-11-25

Dr Gansen Pillay, Deputy Chief Executive Officer of the National Research Foundation, explaining to the scholars what will be expected of them.

The University of the Free State (UFS) can now collect immensely valuable data on drug resistance in HIV/Aids and TB with the new DNA sequencer that was launched recently at the International workshop on HIV/AIDS and TB drug resistance at the Bloemfontein Campus.

The DNA sequencer will allow the Free State province to produce viral and bacterial genetic data to fight the local development of HIV/ Aids and TB drug resistance.

The HIV and TB epidemics have expanded very fast and South Africa now has the largest HIV and TB treatment programme in the world, with over 2 million patients on treatment. However, these successful treatment programmes are now being threatened by the appearance of drug resistance.

The Free State province has been at the forefront of fighting HIV drug resistance in South Africa and has one of the most advanced treatment programmes for the management of resistance strains in the country. In addition, researchers at the University of the Free State are leading partners in the Southern African Treatment and Resistance Network (SATuRN; www.bioafrica.net/saturn), a research network that has trained over 2 000 medical officers in the treatment of drug resistance strains.

The Department of Medical Microbiology and Virology in the Medical School at the UFS has partnered with the provincial department of health, the Medical Research Council (MRC) and the Delegation of the European Union to South Africa to fund a dedicated DNA sequencer machine that will be used to generate HIV and TB drug-resistance results. This new machine will enable cutting-edge research to take place, using the data in the province and, importantly, support patients with resistance strains to have access to advanced genotypic testing techniques.

“HIV drug resistance is a very serious problem in South Africa, and the recent advances in DNA testing technology allow clinicians in the province to access drug resistance testing, which enables them to manage patients appropriately who fail treatment, and use the results to cost-effectively extend and improve patients’ lives,” says Dr Cloete van Vuuren, Specialist in Infectious Diseases at the UFS’s Faculty of Health.

Dr Dominique Goedhals, pathologist from the Department of Medical Microbiology and Virology at the UFS, adds: “We have been looking forward to expanding our work with the clinicians and researchers, using DNA sequencing to shed light on the causes and consequences of drug resistance in urban and rural settings in the province.”

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept